Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2919 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2022-12-22 | 2023-02-09 | 179306 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2023-11-16 | 2023-12-14 | 210428 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2023-11-30 | 2024-01-11 | 211982 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2023-11-30 | 2023-12-07 | 211988 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2023-11-30 | 2024-01-11 | 211992 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2023-12-14 | 2024-02-01 | 213371 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-06-07 | 2024-07-26 | 229954 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2024-07-04 | 2024-09-05 | 232226 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-07-18 | 2024-11-14 | 233267 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-09-05 | 2024-09-19 | 236813 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2024-10-11 | 2024-11-01 | 240049 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-11-08 | 2024-11-21 | 242367 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2025-01-30 | 2025-03-20 | 249204 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2025-06-05 | 2025-07-03 | 259701 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Actual shortage | 2025-11-13 | 2025-11-13 | 271793 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Actual shortage | 2025-11-20 | 2025-12-04 | 272304 |
| TEVA-ATOVAQUONE PROGUANIL | 100MG 250MG | TABLET | Resolved | 2019-10-17 | 2020-03-26 | 96720 |
| TEVA-ATOVAQUONE PROGUANIL | 100MG 250MG | TABLET | Resolved | 2022-12-01 | 2022-12-15 | 176785 |
| TEVA-ATOVAQUONE PROGUANIL | 100MG 250MG | TABLET | Resolved | 2024-11-21 | 2025-02-06 | 243583 |
| TEVA-AZATHIOPRINE | 50MG | TABLET | Resolved | 2019-11-28 | 2020-03-05 | 99941 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |